levothyroxine sodium · Cediprof Inc · NDA 021342

Levo-T

Earliest generic entry, as listed · earliest of 12 marketed strengths
Open now

No marketed reference-listed strength; date taken from all listed strengths.

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 12

NDA · productFormStrengthListed expiry
021342 · 001tablet, oral0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 002tablet, oral0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 003tablet, oral0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 004tablet, oral0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 005tablet, oral0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 006tablet, oral0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 007tablet, oral0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 008tablet, oral0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 009tablet, oral0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 010tablet, oral0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 011tablet, oral0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen
021342 · 012tablet, oral0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodiumopen